{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:02:21Z","timestamp":1776772941675,"version":"3.51.2"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB1066"],"award-info":[{"award-number":["SFB1066"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB1382"],"award-info":[{"award-number":["SFB1382"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.phrs.2024.107560","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T07:14:08Z","timestamp":1735110848000},"page":"107560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8716-0422","authenticated-orcid":false,"given":"Karina","family":"Benderski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayiotis","family":"Kordeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fichter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Schunke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"De Lorenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feyza","family":"Durak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Schr\u00f6rs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"Akilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Kiessling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Bros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Diken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Grabbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn M.","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Twan","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7475-2526","authenticated-orcid":false,"given":"Alexandros Marios","family":"Sofias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Kaps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107560_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107560_bib2","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107560_bib3","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2024.107560_bib4","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41416-020-0823-9","article-title":"Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential","volume":"122","author":"Tsui","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2024.107560_bib5","first-page":"1","article-title":"Lactylome analysis unveils lactylation-dependent mechanisms of stemness remodeling in the liver cancer stem cells","volume":"2405975","author":"Feng","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2024.107560_bib6","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.phrs.2024.107560_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113831","article-title":"Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders","volume":"175","author":"Sofias","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107560_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-18197-6","article-title":"Correlation analysis of metabolic characteristics and the risk of metabolic-associated fatty liver disease - related hepatocellular carcinoma","volume":"12","author":"Xie","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107560_bib9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.24976\/Discov.Med.202436185.103","article-title":"The Role of Extrahepatic Features on the Development and Management of Hepatocellular Carcinoma in Steatotic Liver Disease","volume":"36","author":"Zampaglione","year":"2024","journal-title":"Discov. Med."},{"key":"10.1016\/j.phrs.2024.107560_bib10","first-page":"1","article-title":"Recent advances in systemic therapy for hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2022","journal-title":"Biomark. Res. 2021 101"},{"key":"10.1016\/j.phrs.2024.107560_bib11","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s12276-020-00527-1","article-title":"Hepatocellular carcinoma: old friends and new tricks","volume":"52","author":"Kim","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2024.107560_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2024.107560_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9092027","article-title":"Targeting cancer associated fibroblasts in liver fibrosis and liver cancer using nanocarriers","volume":"9","author":"Kaps","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107560_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073778","article-title":"Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options","volume":"23","author":"Sas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107560_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1047-6","article-title":"Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities","volume":"18","author":"Lu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2024.107560_bib16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41575-018-0033-6","article-title":"Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research","volume":"15","author":"Brown","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107560_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-10-79","article-title":"Mouse model of carbon tetrachloride induced liver fibrosis: histopathological changes and expression of CD133 and epidermal growth factor","volume":"10","author":"Fujii","year":"2010","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.phrs.2024.107560_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1430s66","article-title":"The DEN and CCl4-induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma","author":"Uehara","year":"2014","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107560_bib19","doi-asserted-by":"crossref","first-page":"56095","DOI":"10.18632\/oncotarget.10893","article-title":"Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-\u03baB activation","volume":"8","author":"Gehrke","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2024.107560_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113042","article-title":"Preclinical mouse models of hepatocellular carcinoma: an overview and update","volume":"412","author":"Gu","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.phrs.2024.107560_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100185","article-title":"An orthotopic implantation mouse model of hepatocellular carcinoma with underlying liver steatosis","volume":"1","author":"Kasashima","year":"2020","journal-title":"STAR Protoc."},{"key":"10.1016\/j.phrs.2024.107560_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-46410-6","article-title":"Development of orthotopic tumour models using ultrasound-guided intrahepatic injection","volume":"9","author":"McVeigh","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107560_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171215","article-title":"Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties","volume":"12","author":"Lacoste","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2024.107560_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.15931.1","article-title":"Fastq screen: a tool for multi-genome mapping and quality control","volume":"7","author":"Wingett","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.phrs.2024.107560_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2024.107560_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.phrs.2024.107560_bib27","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","article-title":"Heavy-Tailed prior distributions for sequence count data: removing the noise and preserving large differences","volume":"35","author":"Zhu","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.phrs.2024.107560_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate - a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"10.1016\/j.phrs.2024.107560_bib29","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/adhm.201500826","article-title":"In vivo gene-silencing in fibrotic liver by siRNA-loaded cationic nanohydrogel particles","volume":"4","author":"Kaps","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.phrs.2024.107560_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1101\/pdb.prot073411","article-title":"Manual hematoxylin and eosin staining of mouse tissue sections","volume":"2014","author":"Cardiff","year":"2014","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.phrs.2024.107560_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbrc.2017.02.128","article-title":"IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model","volume":"486","author":"Liu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2024.107560_bib32","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.18632\/aging.102969","article-title":"Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis","volume":"12","author":"Hua","year":"2020","journal-title":"Aging Albany NY"},{"key":"10.1016\/j.phrs.2024.107560_bib33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.64537","article-title":"The landscape of alpha fetoprotein in hepatocellular carcinoma: where are we?","volume":"18","author":"Hu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107560_bib34","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.prp.2018.06.011","article-title":"Microvessel density and angiogenesis in primary hepatic malignancies: differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"214","author":"B\u00f6sm\u00fcller","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.phrs.2024.107560_bib35","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1091\/mbc.E18-05-0319","article-title":"Cancer cells\u2019 ability to mechanically adjust to extracellular matrix stiffness correlates with their invasive potential","volume":"29","author":"Wullkopf","year":"2018","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.phrs.2024.107560_bib36","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jso.21613","article-title":"Mechanical stiffness of liver tissues in relation to integrin \u03b21 expression may influence the development of hepatic cirrhosis and hepatocellular carcinoma","volume":"102","author":"Zhao","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.phrs.2024.107560_bib37","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1158\/0008-5472.CAN-14-0243","article-title":"Transforming growth factor-\u03b2 as a therapeutic target in hepatocellular carcinoma","volume":"74","author":"Giannelli","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2024.107560_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00292-007-0962-2","article-title":"Pathology along the liver sinusoids: endothelial and perisinusoidal findings","volume":"29","author":"Fischer","year":"2008","journal-title":"Pathologe"},{"key":"10.1016\/j.phrs.2024.107560_bib39","first-page":"1","article-title":"Liver X receptor \u03b1 is essential for the capillarization of liver sinusoidal endothelial cells in liver injury","volume":"6","author":"Xing","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107560_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071764","article-title":"Hypoxia, hypoxia-inducible factors and liver fibrosis","volume":"10","author":"Foglia","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107560_bib41","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2024.107560_bib42","first-page":"1","article-title":"Multicompartment polyion complex micelles based on triblock polypept(o)ides mediate efficient siRNA delivery to cancer-associated fibroblasts for antistromal therapy of hepatocellular carcinoma","volume":"2404784","author":"Schneider","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107560_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1152\/physiol.00045.2009","article-title":"Roles for growth factors in cancer progression","volume":"25","author":"Witsch","year":"2010","journal-title":"Physiology"},{"key":"10.1016\/j.phrs.2024.107560_bib44","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s12072-024-10707-0","article-title":"Inflammation of the liver, HCC development and HCC establishment","volume":"18","author":"Kanda","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.phrs.2024.107560_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121503","article-title":"The many roles of cell Adhesion molecules in hepatic fibrosis","volume":"8","author":"Hintermann","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107560_bib46","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.ymthe.2022.01.017","article-title":"Tumor cell E-selectin ligands determine partialefficacy of bortezomib on spontaneous lung metastasis formation of solid human tumors in vivo","volume":"30","author":"Lange","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2024.107560_bib47","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.immuni.2020.04.005","article-title":"Inflammatory Type 2 cDCs acquire features of cDC1s and macrophages to orchestrate immunity to respiratory virus infection","volume":"52","author":"Bosteels","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2024.107560_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phrs.2024.107560_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-73624-w","article-title":"M1 Macrophage and M1\/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer","volume":"10","author":"Oshi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107560_bib50","first-page":"1","article-title":"Harnessing metabolism of hepatic macrophages to aid liver regeneration","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107560_bib51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/35105024","article-title":"T-cell regulation by CD28 and CTLA-4","volume":"1","author":"Alegre","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107560_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-023-01347-8","article-title":"Regulatory T cells (Tregs) in liver fibrosis","volume":"9","author":"Wu","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.phrs.2024.107560_bib53","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/ten.tec.2017.0018","article-title":"A modified hydroxyproline assay based on hydrochloric acid in ehrlich\u2019s solution accurately measures tissue collagen content","volume":"23","author":"Cissell","year":"2017","journal-title":"Tissue Eng.\u00a0Part C\u00a0Methods"},{"key":"10.1016\/j.phrs.2024.107560_bib54","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3892\/or.2016.4660","article-title":"Role of the tumor microenvironment in tumor progression and the clinical applications","volume":"35","author":"Yuan","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phrs.2024.107560_bib55","article-title":"The extracellular matrix in hepatocellular carcinoma: mechanisms and therapeutic vulnerability","volume":"4","author":"Roy","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.phrs.2024.107560_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-46340-4","article-title":"Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype","volume":"13","author":"Wolf","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107560_bib57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002920050155","article-title":"CD34-Nachweis \u00b1\u2009ein immunhistochemischer Beitrag zur Differentialdiagnose von Weichgewebstumoren","volume":"17","author":"Katenkamp","year":"1996","journal-title":"Pathologe"},{"key":"10.1016\/j.phrs.2024.107560_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/hep.23618","article-title":"Liver sinusoidal endothelium: a microenvironment-dependent differentiation program in rat including the novel junctional protein liver endothelial differentiation-associated protein-1","volume":"52","author":"G\u00e9raud","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107560_bib59","first-page":"1","article-title":"Evaluation of INtra-tumoral Vascularization in Hepatocellular Carcinomas","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.phrs.2024.107560_bib60","first-page":"1","article-title":"Biomarkers for cancer-associated fibroblasts","volume":"101","author":"Han","year":"2020","journal-title":"Biomark. Res. 2021"},{"key":"10.1016\/j.phrs.2024.107560_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155303","article-title":"Non-coding RNA mediated regulation of PI3K\/Akt pathway in hepatocellular carcinoma: therapeutic perspectives","volume":"258","author":"Hussain","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.phrs.2024.107560_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-219","article-title":"Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma","volume":"9","author":"Heindryckx","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2024.107560_bib63","article-title":"The clinical significance of the CD163+\u2009and CD68+\u2009macrophages in patients with hepatocellular carcinoma","volume":"8","author":"Kong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2024.107560_bib64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107560_bib65","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41575-021-00568-5","article-title":"Neutrophils as potential therapeutic targets in hepatocellular carcinoma","volume":"19","author":"Geh","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107560_bib66","doi-asserted-by":"crossref","first-page":"511","DOI":"10.21037\/hbsn.2016.11.08","article-title":"New players in non-alcoholic fatty liver disease induced carcinogenesis: lipid dysregulation impairs liver immune surveillance","volume":"5","author":"Tran","year":"2016","journal-title":"HepatoBiliary Surg. Nutr."},{"key":"10.1016\/j.phrs.2024.107560_bib67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jhep.2006.06.005","article-title":"T cell infiltration and prognosis in HCC patients","volume":"45","author":"Parmiani","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107560_bib68","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4314\/ahs.v23i1.22","article-title":"CD4\/CD8 Ratio could be predictor of burden hepatocellular carcinoma in Egyptian chronic hepatitis C after combined sofosbuvir and daclatasvir therapy","volume":"23","author":"El Menshawy","year":"2023","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.phrs.2024.107560_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107560_bib70","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1021\/acs.bioconjchem.6b00348","article-title":"PD-L1 detection in tumors using [64Cu]Atezolizumab with PET","volume":"27","author":"Lesniak","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.phrs.2024.107560_bib71","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/os.12236","article-title":"Inhibition of growth and metastasis of tumor in nude mice after intraperitoneal injection of bevacizumab","volume":"8","author":"Zhao","year":"2016","journal-title":"Orthop. Surg."},{"key":"10.1016\/j.phrs.2024.107560_bib72","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/02713683.2014.943910","article-title":"Bevacizumab revisited: Its use in different mouse models of ocular pathologies","volume":"40","author":"Hollanders","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.phrs.2024.107560_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18091967","article-title":"Biological pathways involved in tumor angiogenesis and bevacizumab based anti-angiogenic therapy with special references to ovarian cancer","volume":"18","author":"Loizzi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107560_bib74","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000505695","article-title":"Dual vascular endothelial growth factor receptor and fibroblast growth factor receptor inhibition elicits antitumor immunity and enhances programmed cell death-1 checkpoint blockade in hepatocellular carcinoma","volume":"9","author":"Deng","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.phrs.2024.107560_bib75","article-title":"Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+\u2009exhausted-like T cells","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107560_bib76","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/hep.30889","article-title":"Dual programmed death receptor-1 and vascular endothelial growth factor receptor-2 blockade promotes vascular normalization and enhances antitumor immune responses in hepatocellular carcinoma","volume":"71","author":"Shigeta","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107560_bib77","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-17-2176","article-title":"Combined VEGF and PD-L1 blockade displays synergistic treatment effects in an autochthonous mouse model of small cell lung cancer","volume":"78","author":"Meder","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2024.107560_bib78","first-page":"1","article-title":"Anti-VEGF antibody triggers the effect of anti-PD-L1 antibody in PD-L1low and immune desert-like mouse tumors","volume":"47","author":"Ishikura","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phrs.2024.107560_bib79","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107560_bib80","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/gut.2003.019984","article-title":"Long term prognosis of fatty liver: risk of chronic liver disease and death","volume":"53","author":"Dam-Larsen","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2024.107560_bib81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/liv.14910","article-title":"Natural history of NASH","volume":"41","author":"Armandi","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.phrs.2024.107560_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44276-024-00050-0","article-title":"Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management","volume":"2","author":"Johnson","year":"2024","journal-title":"BJC Rep."},{"key":"10.1016\/j.phrs.2024.107560_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153651","article-title":"Experimental models of hepatocellular carcinoma\u2014a preclinical perspective","volume":"13","author":"Blidisel","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107560_bib84","author":"Stilliing","year":"2024","journal-title":"Initiat. Transpar. Tierversuche: Netzw. F. \u00fcR. Eine Inf. Debatte"},{"key":"10.1016\/j.phrs.2024.107560_bib85","article-title":"Animal models of hepatocellular carcinoma: the role of immune system and tumor microenvironment","volume":"11","author":"Jilkova","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107560_bib86","first-page":"1566","volume":"77","author":"Zabransky","year":"2023","journal-title":"Profil. syngeneic mouse HCC Tumor Models a Framew. Under anti\u2013PD-1 sensitive Tumor Microenviron."},{"key":"10.1016\/j.phrs.2024.107560_bib87","article-title":"Patient-derived xenograft models in cancer therapy: technologies and applications","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2024.107560_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpz1.852","article-title":"Humanized mouse models for immuno-oncology drug discovery","volume":"3","author":"Kumari","year":"2023","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.phrs.2024.107560_bib89","doi-asserted-by":"crossref","unstructured":"Thorgeirsson, S.S. & Grisham, J.W. Molecular pathogenesis of human hepatocellular carcinoma. 31, (2002).","DOI":"10.1038\/ng0802-339"},{"key":"10.1016\/j.phrs.2024.107560_bib90","unstructured":"Vyas, M. & Jain, D. An update on subtypes of hepatocellular carcinoma: From morphology to molecular. (2021)."},{"key":"10.1016\/j.phrs.2024.107560_bib91","unstructured":"Craig, A.J., Felden, J.Von, Sarcognato, S. & Villanueva, A. Tumour evolution in hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107560_bib92","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2020.12.009","article-title":"Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns,and subtypes","volume":"112","author":"Torbenson","year":"2021","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.phrs.2024.107560_bib93","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.7150\/thno.42539","article-title":"SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2024.107560_bib94","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5009\/gnl16477","article-title":"Pathophysiology and management of alcoholic liver disease: Update 2016","volume":"11","author":"Stickel","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.phrs.2024.107560_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030491","article-title":"Targeting lysyl oxidase family meditated matrix cross-linking as an anti-stromal therapy in solid tumours","author":"Setargew","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107560_bib96","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jcmm.12745","article-title":"Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells","volume":"20","author":"Lu","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2024.107560_bib97","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/liv.14223","article-title":"Biology and significance of alpha-fetoprotein in hepatocellular carcinoma","volume":"39","author":"Galle","year":"2019","journal-title":"Liver Int."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182400505X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182400505X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:37:12Z","timestamp":1740526632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182400505X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":97,"alternative-id":["S104366182400505X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107560","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107560"}}